Global Blood Glucose Test Strip Market to Reach USD 30,404.55 Million by 2032 | CAGR of 6.3%
Category : Pharmaceuticals | Published Date : Jan 2025 | Type : Press Release
Blood Glucose Test Strip Market Scope & Overview:
In the newly published report, Consegic Business Intelligence states that the Blood Glucose Test Strip Market was valued at USD 18,650.52 million in 2024 and is projected to grow at a CAGR of 6.3%, reaching USD 30,404.55 million by 2032. Blood glucose test strips are disposable diagnostic tools used to measure blood glucose levels, primarily for diabetes management. These strips, compatible with glucose meters, are vital for real-time glucose tracking, improving diabetes care, and offering convenience for users. Their applications span type 1 and type 2 diabetes, gestational diabetes, and routine glucose testing.
The report comprises the Blood Glucose Test Strip Market Share, Size & Industry Analysis, based on Material Type (Thick Film Electrochemical Films, Thin Film Electrochemical Films, Optical Strips), Technology (Glucose Oxidase-Based Test Strips, Glucose Dehydrogenase-Based Test Strips), Type (Disposable Test Strips, Reusable Test Strips), Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End-Use (Hospitals, Homecare Settings, Diagnostic Centers, Others), and Region (North America, Europe, Asia-Pacific, Middle East & Africa, Latin America), and Forecast, 2025-2032.
The report contains detailed information on Blood Glucose Test Strip Market Trends, Opportunities, Value, Growth Rate, Segmentation, Geographical Coverage, Company Profiles, In-depth Expert Analysis, Revenue Forecast, Competitive Landscape, Growth Factors, Restraints or Challenges, Environment & Regulatory Landscape, PESTLE Analysis, PORTER Analysis, Key Technology Landscape, Value Chain Analysis, and Cost Analysis.
Growing adoption of portable glucose monitoring devices and advancements in test strip technology drive market growth, while competition from Continuous Glucose Monitoring (CGM) systems presents challenges.
Segmental Analysis :
Based on material type, the market is segmented into Thick Film Electrochemical Films, Thin Film Electrochemical Films, and Optical Strips.
- The thick film electrochemical films segment accounted for the largest share in 2024, driven by their durability, cost-effectiveness, and reliability in glucose monitoring.
- The thin film electrochemical films segment is expected to grow at the fastest rate, fueled by advancements in high-sensitivity materials and eco-friendly designs.
Based on technology, the market is segmented into Glucose Oxidase-Based Test Strips and Glucose Dehydrogenase-Based Test Strips.
- The glucose oxidase-based test strips segment dominated the market in 2024, supported by their compatibility with a wide range of glucometers and affordability.
- The glucose dehydrogenase-based test strips segment is projected to grow at the fastest CAGR, driven by their higher specificity and ability to deliver accurate results, even in complex conditions.
Based on type, the market is segmented into Disposable Test Strips and Reusable Test Strips.
- The disposable test strips segment accounted for the largest revenue share in 2024, attributed to their convenience, single-use nature, and widespread adoption in homecare settings.
- The reusable test strips segment is anticipated to grow at the fastest rate, driven by sustainability trends and cost advantages for frequent testing.
Based on application, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes.
- The type 2 diabetes segment held the largest revenue share of 71.30% in 2024, supported by the increasing prevalence of the disease and emphasis on regular glucose monitoring.
- The gestational diabetes segment is expected to grow at the fastest rate, driven by rising awareness of maternal and fetal health and the increasing prevalence of gestational diabetes.
Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
- The retail pharmacies segment dominated the market in 2024, driven by accessibility and affordability.
- The online pharmacies segment is projected to grow at the fastest CAGR, supported by the rising adoption of e-commerce platforms for healthcare products.
Based on end-use, the market is segmented into Hospitals, Homecare Settings, Diagnostic Centers, and Others.
- The homecare settings segment accounted for the largest share in 2024, attributed to the increasing demand for self-monitoring devices.
- The diagnostic centers segment is anticipated to grow at the fastest rate, supported by investments in advanced diagnostic technologies.
Based on regions, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
- North America: Dominated the market with a valuation of USD 6,186.53 million in 2024, driven by a high prevalence of diabetes and advanced healthcare infrastructure.
- Asia-Pacific: Expected to grow at the fastest CAGR of 6.7%, supported by a growing diabetic population and increasing healthcare investments.
| Report Attributes | Report Details |
| Study Timeline | 2019-2032 |
| Market Size in 2032 | USD 30,404.55 Million |
| CAGR (2025-2032) | 6.3% |
| Material Type | Thick Film Electrochemical Films, Thin Film Electrochemical Films, Optical Strips |
| Technology | Glucose Oxidase-Based Test Strips, Glucose Dehydrogenase-Based Test Strips |
| Type | Disposable Test Strips, Reusable Test Strips |
| Application | Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes |
| Distribution Channel | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
| End-Use | Hospitals, Homecare Settings, Diagnostic Centers, Others |
| By Region | North America(U.S., Canada, Mexico) Europe(U.K., Germany, France, Spain, Italy, Russia, Benelux, Rest of Europe) APAC(China, South Korea, Japan, India, Australia, ASEAN, Rest of Asia-Pacific) Middle East & Africa(GCC, Turkey, South Africa, Rest of MEA) LATAM(Brazil, Argentina, Chile, Rest of LATAM) |
Top Key Players & Competitive Landscape :
The competitive landscape encompasses major innovators, aftermarket service providers, industry giants, and niche players, all of which are thoroughly examined by Consegic Business Intelligence in terms of their strengths, weaknesses, and value-addition potential. This report includes detailed profiles of key players, market share analysis, mergers and acquisitions, resulting market fragmentation, and emerging partnership trends and dynamics.
List of prominent players in the Blood Glucose Test Strip Industry:
- Abbott Laboratories (United States)
- Roche Diagnostics (Switzerland)
- LifeScan, Inc. (United States)
- Ascensia Diabetes Care (Switzerland)
- Dexcom, Inc. (United States)
- B. Braun Melsungen AG (Germany)
- Trividia Health, Inc. (United States)
- AgaMatrix, Inc. (United States)
- Medtronic plc (Ireland)
- Prodigy Diabetes Care, LLC (United States)
Recent Industry Developments :
- June 2024: Abbott Laboratories introduced a new line of glucose test strips with enhanced accuracy and compatibility with leading glucometers, targeting improved diabetes management outcomes.
